骨形态发生蛋白-2单克隆抗体的制备及评价
Development and evaluation of BMP-2 monoclonal antibody
分类号:R917
出版年·卷·期(页码):2018,38 (8):1310-1317
DOI:
10.16155/j.0254-1793.2017.01.01
-----摘要:-------------------------------------------------------------------------------------------
目的:制备骨形态发生蛋白-2(BMP-2)单克隆抗体,并对其进行评价。方法:用重组人源BMP-2蛋白(rhBMP-2)对小鼠进行免疫;确认小鼠血清BMP-2抗体检测阳性后,取其脾细胞与小鼠骨髓瘤细胞按3∶1的比例融合得到杂交瘤细胞株;用间接竞争ELISA法筛选BMP-2阳性单克隆杂交瘤细胞;用常规Protein G进行纯化得到BMP-2单克隆抗体,并对其纯度、表位构相,特异性进行评价。结果:成功制备BMP-2单克隆抗体,其亚型为IgG2a,κ,纯化后的SDS-PAGE纯度大于90%。评价结果表明,本课题组研制的BMP-2抗体与rhBMP-2的结合位点为非线性表位,且特异性优于市售抗体,与BMP家族的BMP-4、BMP-5、BMP-7无交叉反应。结论:本课题组研制的单克隆抗体特异性好,效价高,可用于建立酶联免疫方法,检测骨修复材料中BMP-2含量。
-----英文摘要:---------------------------------------------------------------------------------------
Objective:To develop and evaluate a specific monoclonal antibody against bone morphogenetic protein-2 (BMP-2). Methods:Mice were immunized with the previously developed recombined human BMP-2 (rhBMP-2) protein. When the serum of the mice was tested positive with the BMP-2 antibody,the spleen cells from the mice were isolated and fused with myeloma cells at a ratio of 3:1. Monoclonal hybridoma cells were selected by indirect ELISA using rhBMP-2 as antigen. The BMP-2 antibodies were purified with routine protein G. The purity,epitope conformation and specificity were evaluated. Results:The isotype IgG2a,κ monoclonal antibody against BMP-2 was successfully obtained. The purity of the post-purified product was up to 90% detected by SDS-PAGE. The binding sites of our BMP-2 antibody to rhBMP-2 are linear epitopes,and the specificity of the monoclonal antibody is better than that of the monoclonal antibody available on the market. There were no cross-reactions detected with BMP-4,BMP-5,BMP-7 of the BMP family. Conclusion:The BMP-2 monoclonal antibody developed in this study has high specificity and potency. It can be used for establishing enzyme-linked immunoassay for detecting the content of BMP-2 in bone graft materials.
-----参考文献:---------------------------------------------------------------------------------------
欢迎阅读《药物分析杂志》!您是该文第 1247位读者!